OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory Fibroblast‐Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis
Yuan Liu, Peishi Rao, Hongyan Qian, et al.
Advanced Science (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 34

Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics
Andrés Fernández-Borbolla, Lorena García‐Hevia, Mónica L. Fanárraga
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2071-2071
Open Access | Times Cited: 12

Pathology‐Guided Cell Membrane‐Coated Polydopamine Nanoparticles for Efficient Multisynergistic Treatment of Periodontitis
Shengyuan Pan, Wenjie Zhong, Yuyan Lan, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 9

Biomimetic nanoparticles with cell-membrane camouflage for rheumatoid arthritis
Jingjing Gan, Danqing Huang, Junyi Che, et al.
Matter (2024) Vol. 7, Iss. 3, pp. 794-825
Closed Access | Times Cited: 6

Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis
Hongyan Qian, Chaoqiong Deng, Shiju Chen, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 6

Neutrophil‐Mimetic, ROS Responsive, and Oxygen Generating Nanovesicles for Targeted Interventions of Refractory Rheumatoid Arthritis
Zhuang Tang, Shiyu Meng, Xiaoxue Yang, et al.
Small (2023) Vol. 20, Iss. 20
Closed Access | Times Cited: 14

Metabolic changes in fibroblast-like synoviocytes in rheumatoid arthritis: state of the art review
Zhipeng Hu, Yuan Li, Lili Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Nanoformulation-assisted microneedle transdermal drug delivery system: An innovative platform enhancing rheumatoid arthritis treatment
Yao Wendong, Yan Xingxing, Xie Xianze, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117219-117219
Open Access | Times Cited: 3

Recent Advances of Engineered Cell Membrane‐Based Nanotherapeutics to Combat Inflammatory Diseases
Jiaxin Ma, Linyu Ding, Xuqi Peng, et al.
Small (2024) Vol. 20, Iss. 28
Closed Access | Times Cited: 3

Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment
Yasi Deng, Hao Zheng, Bin Li, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 498-515
Closed Access | Times Cited: 3

Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction
Ming Chen, Shengnan Wang, Yihuan Chen, et al.
Regenerative Biomaterials (2023) Vol. 11
Open Access | Times Cited: 9

Pyroptotic‐Spatiotemporally Selective Delivery of siRNA against Pyroptosis and Autoimmune Diseases
Zongyou Pan, Kaiwang Xu, Guanrui Huang, et al.
Advanced Materials (2024) Vol. 36, Iss. 38
Open Access | Times Cited: 2

Repurposing Indocyanine Green: Exploring the Potential of an Old Drug in Modern Medicine
Xinfei Sun, Yisheng Peng, Pan He, et al.
Nanoscale (2024) Vol. 16, Iss. 24, pp. 11411-11428
Closed Access | Times Cited: 1

Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective
Peng Han, Xiaoying Liu, Jiang He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Nanomedicine targeted anti-inflammatory therapy to deal with the ‘crux’ of rheumatoid arthritis
Min An, Juntao Zhang, Xiaojie Zhang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 4, pp. 381-392
Closed Access

Revolutionizing rheumatoid arthritis therapy: harnessing cytomembrane biomimetic nanoparticles for novel treatment strategies
Lan Ma, Xinchi Jiang, Jianqing Gao
Drug Delivery and Translational Research (2024)
Closed Access

Sinulariolide Suppresses Inflammation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis and Mitigates Collagen-Induced Arthritis Symptoms in Mice
Sen‐Wei Tsai, Yu‐Chieh Cheng, Ya‐Hsuan Chao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8299-8311
Open Access

Mesenchymal Stem Cell-Based Biomimetic Liposome for Targeted Treatment of Rheumatoid Arthritis
Lan Ma, Honghui Wu, Jian Cao, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 36, pp. 47206-47215
Closed Access

Rational formulation of saponin and dexamethasone for the synergistic treatment of rheumatoid arthritis in vivo
Yaru Yue, Zhengquan Liao, Yingqian Zhou, et al.
Applied Materials Today (2024) Vol. 40, pp. 102381-102381
Closed Access

Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy
Qiaoyun Li, Junho Byun, Dongyoon Kim, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 6, pp. 100968-100968
Open Access

Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy
Célia Faustino, Noélia Duarte, Lídia Pinheiro
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 54-54
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top